News and media

Dr Mark Schipp, Australia's Chief Veterinary Officer and Dr Sonya Bennet, Australia's Acting Chief Medical Officer have today declared the Japanese encephalitis virus situation a Communicable Disease Incident of National Significance (CDINS).

Professor Alison McMillan, Chief Nursing and Midwifery Officer, talks about the impacts of alcohol on our health and wellbeing.

We have written feedback for those who applied for our second round of grants under the Primary care Rural Innovative Multidisciplinary Models (PRIMM) grant opportunity. This will assist them in submitting an application in the next round.

The Australian Technical Advisory Group on Immunisation (ATAGI) has updated its recommendations on the use of COVID-19 vaccines for use as a booster.

Japanese encephalitis virus (JEV) has been detected in piggeries in New South Wales, Queensland and Victoria.

Deputy Chief Medical Officer, Dr Ruth Vine, answers the top three questions you've been asking on our social accounts around mental health.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 23 February 2022.

COVID-19 vaccination information kiosks are now open in shopping centres and events in New South Wales, Queensland, Victoria and Western Australia to help you book a vaccination appointment.

People with chronic health conditions or weakened immune systems are at greater risk of getting seriously sick from COVID-19. This includes people living with diabetes, like Nevaeh (pictured).

Vaccination against influenza (flu) is important this year. Vaccination is our best defence against flu viruses.

Deputy Chief Medical Officer, Dr Ruth Vine, answers the top three questions you've been asking on our social accounts around mental health.

The Australian Government is calling on retired, part-time and under-employed health care workers to provide their skills to support the health workforce and the Australian community. Find out how you can get involved.

The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna COVID-19 vaccine in children aged 6 to 11 years.

The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).

COVID-19 vaccination information kiosks are now open in shopping centres New South Wales, Queensland, South Australia, Victoria and Western Australia to help you book a vaccination appointment.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 16 February 2022.

The Schedule of Service Items and Fees (No. 1) 2022 is now available. Verbal maintenance agreements can be provided. The change to service requirements comes into effect 21 February 2022.

The Therapeutic Goods Administration (TGA) has provisionally approved the Spikevax (Moderna) vaccine, for people 6 years and older.